S-1

Company

Inhibrx Biosciences, Inc.

Filed

June 11, 2024

Accession Number

0002007919-24-000011

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →